These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 14718261)

  • 1. Characterization of an anandamide degradation system in prostate epithelial PC-3 cells: synthesis of new transporter inhibitors as tools for this study.
    Ruiz-Llorente L; Ortega-Gutiérrez S; Viso A; Sánchez MG; Sánchez AM; Fernández C; Ramos JA; Hillard C; Lasunción MA; López-Rodríguez ML; Díaz-Laviada I
    Br J Pharmacol; 2004 Feb; 141(3):457-67. PubMed ID: 14718261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ; Tiger G; Ligresti A; López-Rodríguez ML; Di Marzo V
    Eur J Pharmacol; 2004 May; 492(1):1-11. PubMed ID: 15145699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide.
    Day TA; Rakhshan F; Deutsch DG; Barker EL
    Mol Pharmacol; 2001 Jun; 59(6):1369-75. PubMed ID: 11353795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.
    Dickason-Chesterfield AK; Kidd SR; Moore SA; Schaus JM; Liu B; Nomikos GG; Felder CC
    Cell Mol Neurobiol; 2006; 26(4-6):407-23. PubMed ID: 16736384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis, and biological evaluation of new inhibitors of the endocannabinoid uptake: comparison with effects on fatty acid amidohydrolase.
    López-Rodríguez ML; Viso A; Ortega-Gutiérrez S; Fowler CJ; Tiger G; de Lago E; Fernández-Ruiz J; Ramos JA
    J Med Chem; 2003 Apr; 46(8):1512-22. PubMed ID: 12672252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of anandamide transport in FAAH wild-type and knockout neurons: evidence for contributions by both FAAH and the CB1 receptor to anandamide uptake.
    Ortega-Gutiérrez S; Hawkins EG; Viso A; López-Rodríguez ML; Cravatt BF
    Biochemistry; 2004 Jun; 43(25):8184-90. PubMed ID: 15209515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of fatty acid amide hydrolase and monoacylglycerol lipase by the anandamide uptake inhibitor VDM11: evidence that VDM11 acts as an FAAH substrate.
    Vandevoorde S; Fowler CJ
    Br J Pharmacol; 2005 Aug; 145(7):885-93. PubMed ID: 15895107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocannabinoids in the intact retina: 3 H-anandamide uptake, fatty acid amide hydrolase immunoreactivity and hydrolysis of anandamide.
    Glaser ST; Deutsch DG; Studholme KM; Zimov S; Yazulla S
    Vis Neurosci; 2005; 22(6):693-705. PubMed ID: 16469181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake and metabolism of [3H]anandamide by rabbit platelets. Lack of transporter?
    Fasia L; Karava V; Siafaka-Kapadai A
    Eur J Biochem; 2003 Sep; 270(17):3498-506. PubMed ID: 12919314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
    Rockwell CE; Kaminski NE
    J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport.
    Solinas M; Tanda G; Justinova Z; Wertheim CE; Yasar S; Piomelli D; Vadivel SK; Makriyannis A; Goldberg SR
    J Pharmacol Exp Ther; 2007 Apr; 321(1):370-80. PubMed ID: 17210800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conformational requirements for endocannabinoid interaction with the cannabinoid receptors, the anandamide transporter and fatty acid amidohydrolase.
    Reggio PH; Traore H
    Chem Phys Lipids; 2000 Nov; 108(1-2):15-35. PubMed ID: 11106780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlating FAAH and anandamide cellular uptake inhibition using N-alkylcarbamate inhibitors: from ultrapotent to hyperpotent.
    Nicolussi S; Chicca A; Rau M; Rihs S; Soeberdt M; Abels C; Gertsch J
    Biochem Pharmacol; 2014 Dec; 92(4):669-89. PubMed ID: 25283614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Further evidence for the existence of a specific process for the membrane transport of anandamide.
    Ligresti A; Morera E; Van Der Stelt M; Monory K; Lutz B; Ortar G; Di Marzo V
    Biochem J; 2004 May; 380(Pt 1):265-72. PubMed ID: 14969584
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ex vivo imaging of fatty acid amide hydrolase activity and its inhibition in the mouse brain.
    Glaser ST; Gatley SJ; Gifford AN
    J Pharmacol Exp Ther; 2006 Mar; 316(3):1088-97. PubMed ID: 16278311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anandamide uptake is consistent with rate-limited diffusion and is regulated by the degree of its hydrolysis by fatty acid amide hydrolase.
    Kaczocha M; Hermann A; Glaser ST; Bojesen IN; Deutsch DG
    J Biol Chem; 2006 Apr; 281(14):9066-75. PubMed ID: 16461355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental parkinsonism alters endocannabinoid degradation: implications for striatal glutamatergic transmission.
    Gubellini P; Picconi B; Bari M; Battista N; Calabresi P; Centonze D; Bernardi G; Finazzi-Agrò A; Maccarrone M
    J Neurosci; 2002 Aug; 22(16):6900-7. PubMed ID: 12177188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carrier-mediated uptake of the endogenous cannabinoid anandamide in RBL-2H3 cells.
    Rakhshan F; Day TA; Blakely RD; Barker EL
    J Pharmacol Exp Ther; 2000 Mar; 292(3):960-7. PubMed ID: 10688610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progesterone up-regulates anandamide hydrolase in human lymphocytes: role of cytokines and implications for fertility.
    Maccarrone M; Valensise H; Bari M; Lazzarin N; Romanini C; Finazzi-Agrò A
    J Immunol; 2001 Jun; 166(12):7183-9. PubMed ID: 11390466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of anandamide accumulation inhibitors in cerebellar granule neurons: comparison to inhibition of fatty acid amide hydrolase.
    Hillard CJ; Shi L; Tuniki VR; Falck JR; Campbell WB
    J Mol Neurosci; 2007 Sep; 33(1):18-24. PubMed ID: 17901541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.